Press release
Addison’s Disease Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027
The global Addison’s Disease Market is anticipated to grow at a considerable CAGR during the forecast period (2021-2027). The growth of the market is mainly attributed to the increase in the prevalence of Addison’s disease, rising R&D activities to produce new drugs for diagnosis and increasing awareness about Addison’s disease among the population across the globe. The advancement in technologies and several government initiatives also played a vital role in contributing to the growth of the market. Besides, major market players such as Pfizer Inc. GlaxoSmithKline plc, Lupin Pharmaceuticals, Inc., Novartis AG are adopting various strategies such as mergers & acquisition, new product launches, business expansion, and technology innovation to remain competitive in the market.To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/addison-disease-market
The approvals from the FDA for the drugs produced by major market players expected to propel the growth of the market. For instance, in September 2020, Diurnal Group plc had announced that the US Food and Drug Administration (FDA) has approved Alkindi Sprinkle (hydrocortisone granules in capsules for opening). The Alkindi Sprinkle is the replacement therapy for adrenal insufficiency (AI) in infants, children and adolescents (from birth to
Media Contact:
Company name: Orion Market Research
Contact person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Addison’s Disease Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027 here
News-ID: 2285927 • Views: …
More Releases from Orion Market Research
Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become…
Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033.
Railway Management System Market Overview
The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,…
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033.
Monocalcium Phosphate Market Overview
Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The…
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033.
Automotive Lubricants Market Overview
The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by…
More Releases for Addison’s
Addison’s Disease Therapeutics Market Significantly Stepping towards the Succe …
Addison's disease, commonly known as adrenal insufficiency, is a rare ailment in which your body fails to create enough hormones. Your adrenal glands, which are placed directly above your kidneys, produce too little cortisol and, in some cases, too little aldosterone in Addison's disease.
Request Sample Copy of Addison’s Disease Therapeutics Market Report: https://www.infinitybusinessinsights.com/request_sample.php?id=608756
Top Key Players Included in Addison’s Disease Therapeutics Market Report:
Bristol-Myers Squibb
Merck
Novartis
Pfizer
Takeda Pharmaceutical
Bio-Techne
GlaxoSmithKline
Lupin Pharmaceuticals
Abbott
Amgen
Bayer
Biogen
Eli Lilly and Company
Boehringer Ingelheim International
Diurnal
Switzer…
Global Addison’s Disease Drugs Industry Professional Market Analysis by 2020-2 …
This report also researches and evaluates the impact of Covid-19 outbreak on the Addison’s Disease Drugs industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Addison’s Disease Drugs and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Global Addison’s Disease Drugs Market Overview:
GLOBAL INFO RESEARCH has evaluated the global Addison’s Disease Drugs market in its latest research report. The research report,…
Addison’s Disease Treatment Market: Global Markets & Advanced Technologies
Addison's disease is characterized by an uncommon disorder with insufficient production of the steroid hormones known as aldosterone and cortisol from the cells of adrenal glands. Moreover, indications of Addison's disease are known as primary adrenal insufficiency, resulting from insufficient production of two hormones cortisol and aldosterone. Symptoms associated with Addison’s disease include gastrointestinal abnormalities, fatigue, and changes in skin color. Furthermore, mood changes and behavior may occur in some…
Addison’s Disease Treatment Market Latest Trends & Insights 2024
Addison's disease is characterized by an uncommon disorder with insufficient production of the steroid hormones known as aldosterone and cortisol from the cells of adrenal glands. Moreover, indications of Addison's disease are known as primary adrenal insufficiency, resulting from insufficient production of two hormones cortisol and aldosterone. Symptoms associated with Addison’s disease include gastrointestinal abnormalities, fatigue, and changes in skin color. Furthermore, mood changes and behavior may occur in some…
Addison’s Disease Treatment Market : Trends, Opportunities and Forecasts 2024
Addison's disease is characterized by an uncommon disorder with insufficient production of the steroid hormones known as aldosterone and cortisol from the cells of adrenal glands. Moreover, indications of Addison's disease are known as primary adrenal insufficiency, resulting from insufficient production of two hormones cortisol and aldosterone. Symptoms associated with Addison’s disease include gastrointestinal abnormalities, fatigue, and changes in skin color. Furthermore, mood changes and behavior may occur in some…
Addison’s Disease Treatment Market 2024; Market shares and strategies of key p …
Addison's disease is characterized by an uncommon disorder with insufficient production of the steroid hormones known as aldosterone and cortisol from the cells of adrenal glands. Moreover, indications of Addison's disease are known as primary adrenal insufficiency, resulting from insufficient production of two hormones cortisol and aldosterone. Symptoms associated with Addison’s disease include gastrointestinal abnormalities, fatigue, and changes in skin color. Furthermore, mood changes and behavior may occur in some…
